Drug Costs
As Seen In: Pharmaceutical Commerce
Why pharma needs a new path to market
New Pharmaceutical Commerce OpEd explores how direct access is reshaping the future of pharmaceutical market access.
3 ways the modern prescription experience is starting to look more like modern commerce
New direct-to-patient prescription models are emerging as consumers demand the same convenience, transparency, and digital control they experience…
Prescryptive Helps Power LillyDirect®, Supporting Direct-to-Patient Access
Redmond, WA – May 6, 2026 – Prescryptive Health today announced it serves as a technology platform helping to…
More direct ways of selling and buying prescription drugs was the talk at Asembia
At this year’s Asembia Specialty Pharmacy Summit, one theme stood out: the growing momentum behind more direct ways…
NCPDP webinar: How real-time Rx workflow integration puts patients first, saves time & money, and improves outcomes
There’s a shift happening in healthcare – from something done to patients to something managed by consumers. What…
As Seen In: SHRM
GLP-1 pills are here: What does it mean for employers?
Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward.
As Seen In: EBN
As Ozempic costs fall, demand for weight-loss drugs is set to surge
On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…
Direct access isn’t a program – it’s market design
Welcome to a direct access marketplace, where incentives are aligned by design so access becomes the default outcome.
As Seen In: Reuters
Data shows US advertising spend increasing for pharma manufacturers
Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…
Redefining drug access: How the Direct Marketplace helps transform sustainable drug pricing, patient affordability, and innovation
For decades, the U.S. drug distribution model has depended on a complex web of intermediaries — pharmacy benefit…
As Seen In: EBN
A broker’s guide to breaking the rebate cycle
Prescription drug costs are among the fastest-growing and most unpredictable healthcare expenses employers face. According to recent data,…
As Seen In: Drug Topics
Navigating GLP-1 access & complexity: 4 key insights
Glucagon-like peptide-1 (GLP-1) therapies are reshaping care for diabetes, obesity, and cardiometabolic health. Yet with their rapid rise…